TipRanks
Nutra Pharma Corp. (NPHC)
OTHER OTC:NPHC
US Market

Nutra Pharma (NPHC) Income Statement

19 Followers

Nutra Pharma Income Statement

Last quarter (Q2 2026), Nutra Pharma's total revenue was $34.46K, a decrease of -59.23% from the same quarter last year. In Q2, Nutra Pharma's net income was $-3.95M. See Nutra Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 385.31K$ 438.27K$ 97.73K$ 51.90K$ 104.39K
Gross Profit
$ 196.63K$ 249.02K$ 8.47K$ 14.92K$ 34.72K
Operating Expenses
$ 1.66M$ 2.16M$ 1.93M$ 1.10M$ 1.20M
Depreciation and Amortization
$ 101.43K$ 22.68K$ 63.38K$ 67.35K$ 77.38K
EBITDA
$ -1.36M$ -1.88M$ -12.54M$ -365.66K$ -6.25M
Operating Income
$ -1.46M$ -1.91M$ -1.92M$ -924.95K$ -1.17M
Other Income/Expenses
$ -585.05K$ 10.08M$ -11.11M$ 155.76K$ -5.36M
Pretax Income
$ -2.05M$ 8.18M$ -13.10M$ -769.18K$ -6.59M
Net Income
$ -2.05M$ 8.18M$ -13.10M$ -769.18K$ -6.59M
Per Share Metrics
Basic EPS
$ >-0.01$ <0.01$ 0.00$ 0.00$ >-0.01
Diluted EPS
$ >-0.01$ <0.01$ 0.00$ 0.00$ >-0.01
Weighted Average Shares Outstanding
7.78B 19.10B 7.23B 6.61B 4.71B
Weighted Average Shares Outstanding (Diluted)
7.78B 19.10B 7.23B 6.61B 4.71B
Currency in USD

Nutra Pharma Earnings and Revenue History